|
Volumn 302, Issue 5648, 2003, Pages 1138-1139
|
Brain Researchers Try to Salvage Estrogen Treatments
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
ESTROGEN;
PLACEBO;
CONJUGATED ESTROGEN;
MEDROXYPROGESTERONE ACETATE;
NEUROPROTECTIVE AGENT;
PROGESTERONE;
ALZHEIMER DISEASE;
BRAIN CELL;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITION;
DEMENTIA;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
ESTROGEN THERAPY;
HIPPOCAMPUS;
HUMAN;
MEDICAL RESEARCH;
MEMORY;
NEUROPROTECTION;
NONHUMAN;
PREFRONTAL CORTEX;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT OUTCOME;
UNITED STATES;
UTERUS CANCER;
AGE;
AGED;
ANIMAL;
ARTICLE;
BRAIN;
CEREBROVASCULAR ACCIDENT;
CHEMICALLY INDUCED DISORDER;
CONTROLLED CLINICAL TRIAL;
DRUG COMBINATION;
FEMALE;
METABOLISM;
MIDDLE AGED;
NERVE CELL;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
TIME;
AGE FACTORS;
AGED;
ANIMALS;
BRAIN;
CEREBROVASCULAR ACCIDENT;
COGNITION;
DEMENTIA;
DRUG COMBINATIONS;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
ESTROGENS, CONJUGATED (USP);
FEMALE;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
MIDDLE AGED;
NEURONS;
NEUROPROTECTIVE AGENTS;
PATIENT SELECTION;
PROGESTERONE;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TIME FACTORS;
|
EID: 0242497711
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.302.5648.1138 Document Type: Short Survey |
Times cited : (12)
|
References (0)
|